These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 18045114)

  • 1. Transmission of HIV-1 in the face of neutralizing antibodies.
    Blish CA; Blay WM; Haigwood NL; Overbaugh J
    Curr HIV Res; 2007 Nov; 5(6):578-87. PubMed ID: 18045114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maternal but Not Infant Anti-HIV-1 Neutralizing Antibody Response Associates with Enhanced Transmission and Infant Morbidity.
    Ghulam-Smith M; Olson A; White LF; Chasela CS; Ellington SR; Kourtis AP; Jamieson DJ; Tegha G; van der Horst CM; Sagar M
    mBio; 2017 Oct; 8(5):. PubMed ID: 29066544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-1 maternal and infant variants show similar sensitivity to broadly neutralizing antibodies, but sensitivity varies by subtype.
    Mabuka J; Goo L; Omenda MM; Nduati R; Overbaugh J
    AIDS; 2013 Jun; 27(10):1535-44. PubMed ID: 23856624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maternal Neutralization-Resistant Virus Variants Do Not Predict Infant HIV Infection Risk.
    Milligan C; Omenda MM; Chohan V; Odem-Davis K; Richardson BA; Nduati R; Overbaugh J
    mBio; 2016 Feb; 7(1):e02221-15. PubMed ID: 26838723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of neutralizing antibodies in prevention of HIV-1 infection: what can we learn from the mother-to-child transmission context?
    Braibant M; Barin F
    Retrovirology; 2013 Oct; 10():103. PubMed ID: 24099103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Susceptibility of recently transmitted subtype B human immunodeficiency virus type 1 variants to broadly neutralizing antibodies.
    Quakkelaar ED; van Alphen FP; Boeser-Nunnink BD; van Nuenen AC; Pantophlet R; Schuitemaker H
    J Virol; 2007 Aug; 81(16):8533-42. PubMed ID: 17522228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibodies for prevention of mother-to-child transmission of HIV-1.
    Fouda GG; Moody MA; Permar SR
    Curr Opin HIV AIDS; 2015 May; 10(3):177-82. PubMed ID: 25700205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maternal Binding and Neutralizing IgG Responses Targeting the C-Terminal Region of the V3 Loop Are Predictive of Reduced Peripartum HIV-1 Transmission Risk.
    Martinez DR; Vandergrift N; Douglas AO; McGuire E; Bainbridge J; Nicely NI; Montefiori DC; Tomaras GD; Fouda GG; Permar SR
    J Virol; 2017 May; 91(9):. PubMed ID: 28202762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutralization escape variants of human immunodeficiency virus type 1 are transmitted from mother to infant.
    Wu X; Parast AB; Richardson BA; Nduati R; John-Stewart G; Mbori-Ngacha D; Rainwater SM; Overbaugh J
    J Virol; 2006 Jan; 80(2):835-44. PubMed ID: 16378985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV-1 superinfection in women broadens and strengthens the neutralizing antibody response.
    Cortez V; Odem-Davis K; McClelland RS; Jaoko W; Overbaugh J
    PLoS Pathog; 2012; 8(3):e1002611. PubMed ID: 22479183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotypic properties of envelope glycoproteins of transmitted HIV-1 variants from patients belonging to transmission chains.
    Beretta M; Moreau A; Bouvin-Pley M; Essat A; Goujard C; Chaix ML; Hue S; Meyer L; Barin F; Braibant M;
    AIDS; 2018 Sep; 32(14):1917-1926. PubMed ID: 29927786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The breadth and potency of passively acquired human immunodeficiency virus type 1-specific neutralizing antibodies do not correlate with the risk of infant infection.
    Lynch JB; Nduati R; Blish CA; Richardson BA; Mabuka JM; Jalalian-Lechak Z; John-Stewart G; Overbaugh J
    J Virol; 2011 Jun; 85(11):5252-61. PubMed ID: 21411521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unique Phenotypic Characteristics of Recently Transmitted HIV-1 Subtype C Envelope Glycoprotein gp120: Use of CXCR6 Coreceptor by Transmitted Founder Viruses.
    Ashokkumar M; Aralaguppe SG; Tripathy SP; Hanna LE; Neogi U
    J Virol; 2018 May; 92(9):. PubMed ID: 29491151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maternal Humoral Immune Correlates of Peripartum Transmission of Clade C HIV-1 in the Setting of Peripartum Antiretrovirals.
    Mutucumarana CP; Eudailey J; McGuire EP; Vandergrift N; Tegha G; Chasela C; Ellington S; van der Horst C; Kourtis AP; Permar SR; Fouda GG
    Clin Vaccine Immunol; 2017 Aug; 24(8):. PubMed ID: 28566336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of HIV-1 neutralizing and binding antibodies in maternal-infant transmission in Thailand.
    Wieczorek L; Peachman K; Adams DJ; Barrows B; Molnar S; Schoen J; Dawson P; Bryant C; Chenine AL; Sanders-Buell E; Srithanaviboonchai K; Pathipvanich P; Michael NL; Robb ML; Tovanabutra S; Rao M; Polonis VR
    Virology; 2020 Sep; 548():152-159. PubMed ID: 32838936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infant transmitted/founder HIV-1 viruses from peripartum transmission are neutralization resistant to paired maternal plasma.
    Kumar A; Smith CEP; Giorgi EE; Eudailey J; Martinez DR; Yusim K; Douglas AO; Stamper L; McGuire E; LaBranche CC; Montefiori DC; Fouda GG; Gao F; Permar SR
    PLoS Pathog; 2018 Apr; 14(4):e1006944. PubMed ID: 29672607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced Potency and Incomplete Neutralization of Broadly Neutralizing Antibodies against Cell-to-Cell Transmission of HIV-1 with Transmitted Founder Envs.
    Li H; Zony C; Chen P; Chen BK
    J Virol; 2017 May; 91(9):. PubMed ID: 28148796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cloning and characterization of functional subtype A HIV-1 envelope variants transmitted through breastfeeding.
    Rainwater SM; Wu X; Nduati R; Nedellec R; Mosier D; John-Stewart G; Mbori-Ngacha D; Overbaugh J
    Curr HIV Res; 2007 Mar; 5(2):189-97. PubMed ID: 17346133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human immunodeficiency virus type 1 superinfection occurs despite relatively robust neutralizing antibody responses.
    Blish CA; Dogan OC; Derby NR; Nguyen MA; Chohan B; Richardson BA; Overbaugh J
    J Virol; 2008 Dec; 82(24):12094-103. PubMed ID: 18842728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV-1 autologous antibody neutralization associates with mother to child transmission.
    Baan E; de Ronde A; Stax M; Sanders RW; Luchters S; Vyankandondera J; Lange JM; Pollakis G; Paxton WA
    PLoS One; 2013; 8(7):e69274. PubMed ID: 23874931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.